Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2000
11/08/2000CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands
11/07/2000US6143890 Reacting perylene tetracarboxylic-3,4-monoanhydride derivatives with a disubstituted hydrazine
11/07/2000US6143782 Anti-inflammatory and anti-asthma treatment with reduced side effects
11/07/2000US6143767 Piperidinylamino tricyclic compounds as substance P antagonists
11/07/2000US6143765 Enzyme ihibitors of protein
11/07/2000US6143749 Heterocyclic substituted cyclopentane compounds
11/07/2000US6143743 Treatment of nervous system disorders
11/07/2000CA2179306C Dopamine receptor ligands
11/02/2000WO2000064986A1 Novel carbopyronine fluorescence dyes
11/02/2000WO2000064904A1 5,7-bicyclic amidine derivatives useful as nitric oxide synthase inhibitors
11/02/2000WO2000064901A1 Phthalocyanine compounds, water-base ink compositions and colored products
11/02/2000WO2000064900A1 Pyrazolobenzodiazepines as cdk2 inhibitors
11/02/2000WO2000064899A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/02/2000WO2000064484A2 Conjugate having a cleavable linkage for use in a liposome
11/02/2000WO2000042042A3 High affinity inhibitors for target validation and uses thereof
11/02/2000WO2000039130A3 Prenyl transferase inhibitors
11/02/2000WO2000012508B1 Pyrrolbenzodiazepines
11/02/2000EP1047698A1 Piperazino derivatives as neurokinin antagonists
11/02/2000EP1047697A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/02/2000EP1047690A1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission
11/02/2000EP1047677A2 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP1047427A1 Combination of a gaba-a alpha 2/3 agonist and a selective serotonin reuptake inhibitor
11/02/2000DE19919787A1 Color photographic copying material, especially for picture or display, with red-sensitive layer containing pyrazoloazole cyan coupler is compensated for blue and cyan color shift
11/02/2000DE19919119A1 Neue Carbopyronin-Fluoreszenz-Farbstoffe New carbopyronine fluorescent dyes
11/02/2000CA2367738A1 Phthalocyanine compounds, water-base ink compositions and colored products
11/02/2000CA2367682A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/01/2000CN1272111A Tricyclic vasopressin agonists
11/01/2000CN1058013C Process for preparation of novel mercaptoacetylamide derivatives
10/2000
10/31/2000US6140333 For treatment and/or prophylaxis of diseases include such respiratory diseases as chronic obstructive pulmonary diseases, chronic bronchitis, asthma, chronic respiratory obstruction, pulmonary fibrosis, pulmonary emphysema
10/31/2000US6140332 Pyrrolopyrimidines and processes for the preparation thereof
10/31/2000US6140330 Thiazole derivative
10/31/2000US6140322 For therapy or prophylaxis of hypoxia, such as in cases of cardiac arrest, stroke and neonatal hypoxia, neurodegenerative conditions including nerve degeneration and/or nerve necrosis in disorders such as ischaemia, epilepsy, hypoglycemia
10/31/2000US6140318 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
10/31/2000US6140317 Pyrrolopyrimidines and processes for their preparation
10/31/2000US6140033 Support with silver halide emulsions with couplers
10/31/2000CA2151724C Antipyretic and analgesic methods and compositions containing optically pure r-ketorolac
10/31/2000CA2018875C Production of pyrrolopyrimidines and intermediates therefor
10/26/2000WO2000063208A1 Substituted imidazoles, their preparation and use
10/26/2000WO2000063195A1 Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors
10/26/2000WO2000039082A3 1,2-annelated quinoline derivatives
10/26/2000WO2000035919A3 Quinoline derivatives
10/26/2000DE19918725A1 New heterocyclic-substituted N-cyano-sulfonanilide compounds, useful as total or selective pre- or post-emergence herbicides, showing desiccant, defoliant, germination inhibiting and especially weed-killing activities
10/25/2000EP1045851A1 Substituted porphyrins
10/25/2000EP1045850A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
10/25/2000EP1045849A1 Purine derivatives having phosphodiesterase iv inhibition activity
10/25/2000EP1045838A1 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
10/25/2000EP0751950B1 Method for identifying members of combinatorial libraries
10/25/2000CN1271359A Novel compounds
10/25/2000CN1271338A Processes and intermediates useful to make antifolates
10/25/2000CN1057764C Method for producing ferriporphyrin from chlorophyll
10/25/2000CN1057755C Fluoroalkenyl compounds and preparing method
10/24/2000US6137002 Glycoprotein IIb/IIIa antagonists
10/24/2000US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
10/24/2000US6136966 Phthalocyanine radical anions and process for producing the same
10/24/2000US6136841 Complexes; medical diagnosis
10/24/2000US6136809 Azolo triazines and pyrimidines
10/24/2000US6136800 Steroids
10/19/2000WO2000061783A2 Process for preparing inhibitors of nucleoside metabolism
10/19/2000WO2000061586A1 Bicyclic heteroaromatic compounds useful as lh agonists
10/19/2000WO2000061585A2 1,3-dipolar cycloadditions to polypyrrolic macrocycles
10/19/2000WO2000061584A1 IMPROVED β,β,-DIHYDROXY MESO-SUBSTITUTED CHLORINS, ISOBACTERIOCHLORINS, AND BACTERIOCHLORINS
10/19/2000WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors
10/19/2000WO2000061569A1 Adamantane derivatives
10/19/2000WO2000012507A8 Pyrrolobenzodiazepines
10/19/2000CA2696826A1 Process for preparing inhibitors of nucleoside metabolism
10/19/2000CA2369981A1 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
10/19/2000CA2368829A1 Adamantane derivatives
10/18/2000EP1044976A1 Process for the preparation of pirlindole hydrochloride
10/18/2000EP1044586A2 Highly transparent non-metallic cathodes
10/18/2000EP1044201A1 3-substituted adenines via2-thioxanthines
10/18/2000EP1044197A2 New piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/18/2000EP1044001A1 Integrin receptor antagonists
10/18/2000EP0633886B1 Pharmaceutically active bicyclic-heterocyclic amines
10/18/2000CN1270593A Pyrimidin-4-one and pyrimidin-4-thione as fungicide
10/18/2000CN1270591A Novel compounds
10/18/2000CN1270590A Novel compounds
10/18/2000CN1270170A Resolution of [R,S]-alpha-(methoxyimido)-alpha-(1-azebicyclic [2,2,2] octa-3-radical) acetonitrile
10/18/2000CN1270166A Derivatives of tricyclo-substituted isohydroxyloxime acid
10/18/2000CN1057529C Production of triethylenediamine using surface acidity deactivated zeolite catalysts
10/18/2000CN1057528C Process for producing triethyldiamine
10/18/2000CN1057527C Synthesis of triethylenediamine as catalyst with base-treated zeolites
10/18/2000CN1057526C Novel crystal modification of diketopyrrolopyrrole pigment
10/18/2000CN1057525C Process improvement in synthesis of N-[3-(3-cyanopyrazolo [1,5-alpha] pyrimidin-7-yl] phenyli-N-ethyl-acetamide
10/17/2000US6133283 Mono- or polyenic carboxylic acid derivatives
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/17/2000US6133273 Disorders associated with bone loss by increased transcription and elevation of plasma calcitonin levels including paget's disease, post menopausal osteoporosis, senile osteoporosis, and glucocorticoid-induced osteoporosis
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000CA2022484C 1-(pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments
10/17/2000CA2001205C Antimicrobial quinolonyl lactams
10/12/2000WO2000060014A1 Phthalocyanine compounds, process for producing the same, and near infrared absorbent comprising the same
10/12/2000WO2000059908A2 Pyrazolopyrimidines as crf antagonists
10/12/2000WO2000059907A2 Pyrazolotriazines as crf antagonists
10/12/2000WO2000059884A1 Pharmaceutically active compounds and methods of use thereof
10/12/2000WO2000059510A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000WO2000059505A1 Inhibitors for vascular reconstriction after angioplasty
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2484282A1 Pyrimidine derivatives intermediates for producing aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
1 ... 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 ... 573